Big endothelin-1 as a predictor of atrial fibrillation recurrence after primary ablation only in patients with paroxysmal atrial fibrillation

Herz

Volumn 37, Issue 8, 2012, Pages 919-925

  Wang, H ^a   Liu, J ^b   Fang, P ^b   Lei, S ^b   Li, X ^b   Hou, Y ^b   Zhang, S ^b  

^a BENGBU MEDICAL COLLEGE   (China)

^b FUWAI HOSPITAL   (China)

Author keywords

Atrial fibrillation; Big endothelin 1; Circumferential pulmonary vein ablation; Recurrence

Indexed keywords

BIG ENDOTHELIN 1; BIOLOGICAL MARKER; ENDOTHELIN 1;

ABLATION THERAPY; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SINUS RHYTHM; BLOOD; CHINA; CLINICAL TRIAL; INCIDENCE; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CHINA; ENDOTHELIN-1; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RECURRENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84878895312     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-012-3626-9     Document Type: Article

References (15)

1. Haissaguerre M, Jais P, Shah DC (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659-666
2. Calkins H, Brugada J, Packer DL (2007) HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 4:816-861
3. Liu J, Fang PH, Hou Y (2010) The value of transtelephonic electrocardiogram monitoring system during the "Blanking Period" after ablation of atrial fibrillation. J Electrocardiol 43:667-672
4. Kourliouros A, Savelieva I, Kiotsekoglou A (2009) Current concepts in the pathogenesis of atrial fibrillation. Am Heart J 157:243-252
5. Liu J, Fang PH, Dibs S (2011) High-sensitivity C-reactive protein as a predictor of atrial fibrillation recurrence after primary circumferential pulmonary vein isolation. Pacing Clin Electrophysiol 34:398-406
6. Hemsen A, Ahlborg G, Ottosson-Seeberger A (1995) Metabolism of Big endothelin-1 (1-38) and (22-38) in the human circulation in relation to production of endothelin-1 (1-21). Regul Pept 55:287-297
7. Nakazawa Y, Ashihara T, Tsutamoto T (2009) Endothelin-1 as a predictor of atrial fibrillation recurrence after pulmonary vein isolation. Heart Rhythm 6:725-730
8. Brundel BJ, Van Gelder IC, Tuinenburg AE (2001) Endothelin system in human persistent and paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 12:737-742
9. Washizuka T, Horie M, Watanuki M (1997) Endothelin-1 inhibits the slow component of cardiac delayed rectifier K+currents via a pertussis toxin-sensitive mechanism. Circ Res 81:211-218
10. Tuinenburg AE, Van Veldhuisen DJ, Boomsma F (1998) Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm. Am J Cardiol 81:1207-1210
11. Kolettis TM, Kyriakides ZS, Zygalaki E (2008) Endothelin system and atrial fibrillation post-cardiac surgery. J Interv Card Electrophysiol 21:203-208
12. Watts SW, Thakali K, Smark C (2007) Big ET-1 processing into vasoactive peptides in arteries and veins. Vascul Pharmacol 47:302-312
13. Masson S, Latini R, Anand IS (2006) The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT). J Card Fail 12:375-380
14. Matsuo S, Lellouche N, Wright M (2009) Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation. J Am Coll Cardiol 54:788-795
15. Berruezo A, Tamborero D, Mont L (2007) Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J 28:836-841